Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis.

Erythropoiesis-stimulating agents are used to treat anemia in patients with cancer. However, their safety and effectiveness is controversial. We did a systematic review of the clinical efficacy and harms of these agents in adults with anemia related to cancer or chemotherapy.